RWCRF yields 740.74% · JNJ yields 2.13%● Live data
📍 RWCRF pulled ahead of the other in Year 1
Combined, RWCRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RWCRF + JNJ for your $10,000?
RIWI Corp. operates as a trend-tracking and prediction technology firm in the United States, Canada, Europe, and internationally. Its patented cloud-based software solution provides global digital intelligence platform to clients seeking real-time citizen sentiment data. The company offers subscription products, such as RIWI compass to gauge the extent of political and geopolitical risks; RIWI Alpha which provides real-time data on consumer demand and purchase signals for electric vehicles and luxury goods; and RIWI high-frequency economic data stream which provides data on consumer intentions, jobs, and personal income in real-time. It also provides data solutions, including RIWI track for custom surveys and continuous trend tracking, measurement, and prediction; RIWI test, a concept, ad, and message testing; RIWI audience to scale online engagement initiatives or platforms; RIWI rapid response, to assess critical situations; and RIWI omnibus to source answers to a few questions using random domain intercept technology. The company serves government and public sector, financial services, healthcare, international development, and consumer service industries. RIWI Corporation was incorporated in 2009 and is headquartered in Toronto, Canada.
Full RWCRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.